Completed OBSERVATIONAL NCT01654848

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients (HITOLT)

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients: a Prospective Multivariate Analysis of Prognostic Factors and Haemostaseological Findings

Sponsor: CHIR-Net

Conditions Heparin-induced Thrombocytopenia Liver Transplantation

Updated 6 times since 2017 Last updated: Jul 31, 2012 Started: Jan 31, 2010 Primary completion: Aug 31, 2011 Completion: Aug 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Heparin-induced Thrombocytopenia and Liver Transplantation and is currently completed. CHIR-Net leads this study, which shows 6 recorded versions since 2010 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 1 earlier version

Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CHIR-Net
University Medicine Greifswald

Data source: CHIR-Net

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Munich, Germany